An avalanche of lawsuits filed against Bayer in Missouri is pitting the chemical maker against trial attorneys and cancer patients.
Other European pharma groups, including AstraZeneca, GSK, Roche, and Sanofi, have all also upgraded their revenue forecasts after a strong first half. Bayer's cell therapy for Parkinson's disease ...